AHA, Others Comment to DEA on Controlled Substances Quotas

The AHA and six other organizations comments to the Drug Enforcement Administration on its proposed rule regarding controlled substances quotas.  Although the organizations support DEA’s efforts to combat diversion, there is concern that the proposed rule is focused on diversion to the exclusion of another critical factor – drug shortages. 

Related Resources

Toolkits/Methodology
Strengthening the Health Care Workforce Digital Toolkit contains social media posts and images to support your team through burnout, to address behavioral…
Guides/Reports
As we chart a new path together, we have developed this new resource – under the guidance of the AHA Board of Trustees’ Task Force on Workforce and with input…
Fact Sheets
The AHA urges Congress and the Biden Administration to prioritize funding for the infrastructure that supports the health care workforce needs of the country…
Advancing Health Podcast
Public
Leading care teams through COVID-19 has been a challenge unlike any other.
Fact Sheets
Public
Congress should enact the Safety from Violence for Healthcare Employees (SAVE) Act, which provides health care workplace protections against violence similar…
Letter/Comment
Public
AHA provides feedback on the Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act (S.4348).